Richter takes 'initial steps' to BGS bond issue
Image by Richter.hu
Pharmaceutical company Gedeon Richter last week said its management had taken "initial steps" to participate in the Bond Funding for Growth Scheme (BGS) of the National Bank of Hungary (MNB), according to an announcement on the website of the Budapest Stock Exchange.
A decision on participation in the scheme, with the issue of a 10-year bond, will be taken by Richter's board. The company's decision related to the potential scale, coupon and timing of such an issue will be taken at a later date, Richter said.
The blue-chip pharma firm added that it had initiated a review of its external funding framework "in order to improve [its] acquisition capabilities."
The MNB launched the BGS in the summer of 2019 with the aim of beefing up Hungary's relatively small corporate bond market. The program allocation stands at HUF 1.15 trillion.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.